News &amp; Updates

The combination of mesalamine plus corticosteroid does not appear to be more beneficial than corticosteroid alone in the treatment of hospitalized patients with acute severe ulcerative colitis (UC), as shown in a study.

XtraFocus pinhole device clears vision in pseudophakic patients

The XtraFocus pinhole device can help reduce glare and improve vision in pseudophakic patients with irregular corneal astigmatism or intragenic iris trauma, reports a recent study.

Frequent cannabis use poses risk of psychosis

Individuals who use cannabis weekly or more frequently appear to be at heightened risk of psychosis, as reported in a study.

Anaphylaxis after COVID mRNA vaccination relatively rare

Anaphylactic reactions warranting treatment after receipt of COVID-19 mRNA vaccinations appear to be relatively rare, according to a US study presented at AAAAI 2022.

06 Apr 2022

Heart-healthy diet boosts cognitive development during youth

A diet low in cholesterol and saturated fatty acids, initiated and maintained from infancy, seems to improve cognitive flexibility and inhibitory control at young adulthood, reports a new study.

Add-on amantadine lessens “off” episodes in Parkinson’s disease

A delayed release/extended release (DR/ER) formulation of amantadine can help reduce breakthrough symptoms in Parkinson’s disease patients when the effect of levodopa therapy wears off, as shown in a recent study.

06 Apr 2022

Prophylactic anticoagulants, pharmacy oversight lower VTE risk in multiple myeloma

Treatment with a guideline-based thromboprophylaxis in multiple myeloma patients and the addition of pharmacy oversight to risk assessment can help reduce the risk of venous thromboembolism (VTE), suggests a recent study.

06 Apr 2022

Unsafe practices in handling chemotherapy persist in poorer countries

Handling of chemotherapy drugs remains unsafe in many low- (LICs) and middle-income countries (LMICs), reveals a study.

$Relapsed/refractory multiple myeloma patients burdened with poor survival, high costs$

Relapsed/refractory multiple myeloma patients burdened with poor survival, high costs

Patients with relapsed/refractory multiple myeloma (RRMM) are at greater risk of adverse events (AEs), have low overall survival (OS), and suffer a substantial economic burden, reports a study, which suggests the need for effective treatment options.

06 Apr 2022

SGLT2i lowers serum urate regardless of diabetes status